000014181 001__ 14181
000014181 005__ 20250112183548.0
000014181 022__ $$2(DE-600)1182884-5$$a1354-3784
000014181 022__ $$a1354-3784$$l1744-7658
000014181 022__ $$a1744-7658
000014181 0247_ $$2ZDBID$$aPERI:(DE-600)2030114-5
000014181 0247_ $$2ZDBPPN$$aZDPPN:020990359
000014181 0247_ $$2EZBID$$aPERI:(DE-606)8539
000014181 0247_ $$2OCLC$$aOCLC:1368159265
000014181 0247_ $$2JCR$$aJCR:EXPERT OPIN INV DRUG
000014181 0247_ $$2ISI$$aWOS:EXPERT OPINION ON INVESTIGATIONAL DRUGS
000014181 0247_ $$2SCOPUS$$aSCOPUS:21351
000014181 0247_ $$2Medline$$amedline:9434197
000014181 035__ $$aPERI:(DE-600)2030114-5
000014181 040__ $$a0355$$bger$$cDE-101$$dJOIN²$$eJOIN² journal identification
000014181 041__ $$aeng
000014181 044__ $$cXA-GB
000014181 082__ $$222sdnb$$a610$$qDE-600
000014181 08274 $$222sdnb$$a610$$qDE-600
000014181 084__ $$2fid$$aPHARM$$qDE-84
000014181 084__ $$2ssgn$$a15,3
000014181 2100_ $$2DE-600$$aExpert Opin Investig Drugs
000014181 2100_ $$2dnlm$$aExpert Opin Investig Drugs
000014181 2100_ $$2iso$$aExpert Opin Investig Drugs
000014181 24220 $$2DE-600$$aExpert opinion on investigational drugs$$bEOID$$yen
000014181 24220 $$2DE-600$$aExpert opinion on investigational drugs$$bEOID
000014181 245__ $$2DE-600$$aExpert opinion on investigational drugs$$bEOID$$hprint, online
000014181 2463_ $$2DE-600$$aExpert opinion on investigational drugs
000014181 2463_ $$aExpert opinion on investigational drugs
000014181 2463_ $$aEOID
000014181 260__ $$aAbingdon, Oxon$$bRoutledge, Taylor & Francis$$c1994-
000014181 260_1 $$0Host:(DE-Juel1)46$$2DE-Juel1$$aTaylor & Francis
000014181 26421 $$3anfangs$$aLondon [u.a.]$$bInforma Healthcare
000014181 26431 $$aAbingdon, Oxon$$bRoutledge, Taylor & Francis$$c1994-
000014181 3620_ $$2DE-600$$aNachgewiesen 3.1994 -
000014181 36301 $$2DE-600$$81.1\x$$a3$$i1994
000014181 380__ $$2marcgt$$ajournal
000014181 500__ $$aAutomatically generated record. (Updated: 2024-12-18)
000014181 650_7 $$0ASJC:2736$$2ASJC$$aPharmacology (medical)
000014181 650_7 $$0ASJC:3004$$2ASJC$$aPharmacology
000014181 77608 $$2DE-600$$dLondon : Informa Healthcare, 1994-$$iErscheint auch als$$nDruck-Ausgabe$$tExpert opinion on investigational drugs$$w(DE-600)1182884-5$$x1354-3784
000014181 8564_ $$d0$$uhttps://ezb.ur.de/?2030114-5$$yEZB
000014181 8564_ $$d0$$uhttps://www.tandfonline.com/loi/ieid20$$yVerlag; 3.1994 - 18.2009 = Deutschlandweit zugänglich
000014181 8801_ $$2DE-600$$aExpert opinion on investigational drugs$$bEOID
000014181 909CO $$ooai:juser.fz-juelich.de:74187$$pauthority$$pauthority:PERI
000014181 909CO $$ooai:juser.fz-juelich.de:74187
000014181 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEXPERT OPIN INV DRUG : 2022$$d2024-12-18
000014181 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-18
000014181 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-18
000014181 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-18
000014181 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-18
000014181 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-18
000014181 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-18
000014181 915__ $$0StatID:(DE-HGF)1120$$2StatID$$aDBCoverage$$bBIOSIS Reviews Reports And Meetings$$d2024-12-18
000014181 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-18
000014181 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-18
000014181 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bEXPERT OPIN INV DRUG : 2022$$d2024-12-18
000014181 980__ $$aPERI
000014181 980__ $$aAUTHORITY